Skip to main content
  • 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in low-grade gliomas

    Final Number:

    Pablo A. Valdes PhD; Valerie L Jacobs BS; Brent T. Harris MD, PhD, FCAP; Brian Wilson; Frederic Leblond; Keith Paulsen PhD; David W. Roberts MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: Fluorescence-guided resection using 5-aminolevulinic acid-induced protoporphyrin IX (ALA-PpIX) has shown promising results in high-grade gliomas. However, few studies have investigated the utility of ALA-PpIX in low-grade gliomas. We have previously shown significantly improved diagnostic performance in high-grade gliomas using a quantitative technique for fluorescence-guidance compared to state-of-the-art visible fluorescence imaging techniques. Here we present our initial experience using both visible, subjective fluorescence and quantitative fluorescence in low-grade gliomas.

    Methods: Twelve patients with a diagnosis of low-grade glioma were administered 20mg/kg of ALA prior to surgery under an IRB approved protocol. Assessments of the visible, red fluorescence and quantitative measurements of PpIX concentrations (CPpIX) were obtained from multiple locations intraoperatively, and subsequently biopsy specimens underwent neuropathological analysis. Receiver operating characteristic (ROC) analysis to assess the diagnostic performance of both fluorescence guidance techniques was performed.

    Results: Five out of 12 tumors demonstrated at least one instance of visible fluorescence. Normal tissue presented with a mean CPpIX=51.0 ng/ml [min=0.0,25th-percentile=1.0,75th-percentile=5.0,max-567.0], while tumor had a mean CPpIX=766.0 ng/ml [min=0.0,25th-percentile=1.0,75th-percentile=177.0,max=10540.0]. ROC analysis of visible fluorescence yielded a diagnostic accuracy of 38.0%(cut-off threshold=visible fluorescence score >=1, AUC=0.514), whereas quantitative fluorescence yielded a diagnostic accuracy of 67 % (for a cut-off threshold of CPpIX>5.6 ng/mL, AUC=0.66). Further, 45% (9/20) of tumor specimens that were not visibly fluorescent, which would have otherwise gone undetected, accumulated diagnostically significant levels of CPpIX using quantitative fluorescence measurements.

    Conclusions: This initial experience of ALA-PpIX in LGG concurs with the literature understanding that visible fluorescence results in poor diagnostic accuracies. We found diagnostically significant levels of CPpIX in LGGs that were non-visibly fluorescent and below the visible fluorescence detection threshold. Further, in this initial experience using quantitative methods, we found that the diagnostic performance of ALA-PpIX in LGG approaches that of visible methods for high-grade gliomas.

    Patient Care: This work presents the use of quantitative fluorescence as a surgical adjunct in 5-aminolevulinic acid-induced protoporphyrin IX fluorescence guidance in low-grade gliomas

    Learning Objectives: 1. Review the literature experience to date in the neurosurgical community using ALA-PpIX for fluorescence guided surgery in low-grade gliomas 2. Understand the difference between visible and quantitative techniques for fluorescence guided surgery by having a basic understanding of light-tissue interactions and biomedical optics 3. Understand the fundamental process, techniques, and intraoperative implementation of quantitative fluorescence techniques

    References: 1. Colditz MJ, Jeffree RL: Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies. J Clin Neurosci 19:1471-1474, 2012 2. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006 3. Valdes PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X, et al: Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 115:11-17, 2011

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy